Dr De Reuck’s research interests focus on treatment and management of stroke, epilepsy and Parkinson’s disease. He is especially interested in stroke prevention and atrial fibrillation, cerebral blood flow and oxygen metabolism in borderzone and territorial infarcts, CADASIL (Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy), the pathophysiology of carotid artery disease and related clinical syndromes, Parkinsonism in patients with cerebral infarcts, and vagus nerve stimulation for refractory epilepsy.
Dr De Reuck is or has been a principle investigator in the Stroke and Atrial Fibrillation Ensemble (SAFE) II study, and in the Piracetam Acute Stroke Study (PASS). He is the chairman of the Congress Programme Committee of the European Federation of Neurological Societies (EFNS) and a member of the European Task Force on Age-Related White Matter Changes. He has authored 500+ peer reviewed publications.
Dr De Reuck is Past President of the European Federation of Neurological Societies (EFNS)